Warning: The NCBI web site requires JavaScript to function. more...
Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry.
Salido M, Tusquets I, Corominas JM, Suarez M, Espinet B, Corzo C, Bellet M, Fabregat X, Serrano S, Solé F.
Breast Cancer Res. 2005;7(2):R267-73. Epub 2005 Jan 26.
Related citations
[Analysis of HER2 gene status in breast cancer with HER2 protein overexpression].
Zeng X, Liang ZY, Wu SF, Zhou WX, Gao J, Liu TH.
Zhonghua Bing Li Xue Za Zhi. 2006 Oct;35(10):584-8. Chinese.
The effect of chromosome 17 polysomy on HER-2/neu status in breast cancer.
Hyun CL, Lee HE, Kim KS, Kim SW, Kim JH, Choe G, Park SY.
J Clin Pathol. 2008 Mar;61(3):317-21. Epub 2007 Aug 30.
Analysis of ERBB2 and TOP2A gene status using fluorescence in situ hybridization versus immunohistochemistry in localized breast cancer.
Bouchalová K, Trojanec R, Kolár Z, Cwiertka K, Cernáková I, Mihál V, Hajdúch M.
Neoplasma. 2006;53(5):393-401.
[HER2 status in breast cancer of Chinese women: a study of 1170 cases using fluorescence in-situ hybridization].
Zeng X, Liang ZY, Wu SF, Gao J, Zhou WX, Liu TH.
Zhonghua Bing Li Xue Za Zhi. 2008 Sep;37(9):594-8. Chinese.
Aneusomy 17 in breast cancer: its role in HER-2/neu protein expression and implication for clinical assessment of HER-2/neu status.
Wang S, Hossein Saboorian M, Frenkel EP, Haley BB, Siddiqui MT, Gokaslan S, Hynan L, Ashfaq R.
Mod Pathol. 2002 Feb;15(2):137-45.
Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray-based CGH analysis.
Marchiò C, Lambros MB, Gugliotta P, Di Cantogno LV, Botta C, Pasini B, Tan DS, Mackay A, Fenwick K, Tamber N, Bussolati G, Ashworth A, Reis-Filho JS, Sapino A.
J Pathol. 2009 Sep;219(1):16-24.
Polysomy 17 in HER-2/neu status elaboration in breast cancer: effect on daily practice.
Ma Y, Lespagnard L, Durbecq V, Paesmans M, Desmedt C, Gomez-Galdon M, Veys I, Cardoso F, Sotiriou C, Di Leo A, Piccart MJ, Larsimont D.
Clin Cancer Res. 2005 Jun 15;11(12):4393-9.
PGDS, a novel technique combining chromogenic in situ hybridization and immunohistochemistry for the assessment of ErbB2 (HER2/neu) status in breast cancer.
Ni R, Mulligan AM, Have C, O'Malley FP.
Appl Immunohistochem Mol Morphol. 2007 Sep;15(3):316-24.
Poor prognostic significance of unamplified chromosome 17 polysomy in invasive breast carcinoma.
Krishnamurti U, Hammers JL, Atem FD, Storto PD, Silverman JF.
Mod Pathol. 2009 Aug;22(8):1044-8. Epub 2009 Apr 24.
Protein overexpression and gene amplification of c-erbB-2 in breast carcinomas: a comparative study of immunohistochemistry and fluorescence in situ hybridization of formalin-fixed, paraffin-embedded tissues.
Kobayashi M, Ooi A, Oda Y, Nakanishi I.
Hum Pathol. 2002 Jan;33(1):21-8.
Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization.
Jimenez RE, Wallis T, Tabasczka P, Visscher DW.
Mod Pathol. 2000 Jan;13(1):37-45.
Analysis of aneusomy level and HER-2 gene copy number and their effect on amplification rate in breast cancer specimens read as 2+ in immunohistochemical analysis.
Merola R, Mottolese M, Orlandi G, Vico E, Cognetti F, Sperduti I, Fabi A, Vitelli G, Cianciulli AM.
Eur J Cancer. 2006 Jul;42(10):1501-6. Epub 2006 Jun 9.
Impact of polysomy 17 on HER-2/neu immunohistochemistry in breast carcinomas without HER-2/neu gene amplification.
Lal P, Salazar PA, Ladanyi M, Chen B.
J Mol Diagn. 2003 Aug;5(3):155-9.
Analysis of EGFR, HER2, and TOP2A gene status and chromosomal polysomy in gastric adenocarcinoma from Chinese patients.
Liang Z, Zeng X, Gao J, Wu S, Wang P, Shi X, Zhang J, Liu T.
BMC Cancer. 2008 Dec 6;8:363.
Her-2/neu gene amplification in low to moderately expressing breast cancers: possible role of chromosome 17/Her-2/neu polysomy.
Bose S, Mohammed M, Shintaku P, Rao PN.
Breast J. 2001 Sep-Oct;7(5):337-44.
Relative quantification of ERBB2 mRNA in invasive duct carcinoma of the breast: correlation with ERBB-2 protein expression and ERBB2 gene copy number.
Mrhalová M, Kodet R, Kalinová M, Hilská I.
Pathol Res Pract. 2003;199(7):453-61.
Does polysomy of chromosome 17 have a role in ERBB2 and topoisomerase IIalpha expression? Gene, mRNA and protein expression: a comprehensive analysis.
Corzo C, Bellosillo B, Corominas JM, Salido M, Coll MD, Serrano S, Albanell J, Solé F, Tusquets I.
Tumour Biol. 2007;28(4):221-8. Epub 2007 Aug 23.
Assessment of HER-2/neu overexpression and/or gene amplification in breast carcinomas: should in situ hybridization be the method of choice?
Sauer T, Wiedswang G, Boudjema G, Christensen H, Karesen R.
APMIS. 2003 Mar;111(3):444-50.
HER-2 status in breast cancer: correlation of gene amplification by FISH with immunohistochemistry expression using advanced cellular imaging system.
Ciampa A, Xu B, Ayata G, Baiyee D, Wallace J, Wertheimer M, Edmiston K, Khan A.
Appl Immunohistochem Mol Morphol. 2006 Jun;14(2):132-7.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on